Search results
FDA Approves Pharming's Immune Disorder Drug, As First APDS Therapy
Benzinga via Yahoo Finance· 1 year agoThe FDA approved Pharming Group N.V.'s (NASDAQ: PHAR) Joenja (leniolisib) for activated...
US FDA approves Pharming's immune disorder drug
Reuters via Yahoo News· 1 year ago(Reuters) -The U.S. Food and Drug Administration (FDA) on Friday approved Pharming Group's drug to treat a rare genetic disorder that leads to a weakened...
Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up
Zacks via Yahoo Finance· 1 year agoPharming Group (PHAR) obtains FDA approval for leniolisib for the treatment of a rare pediatric...
Pharming's Leniolisib Goes Under Priority FDA Review For Rare Immune System Disorder
Benzinga via Yahoo Finance· 2 years agoThe FDA has accepted Pharming Group NV's (NASDAQ: PHAR) marketing application seeking approval for...
Pharming Highlights Interim Data From Rare Immune Deficiency Study
Benzinga via Yahoo Finance· 1 year agoPharming Group N.V. (NASDAQ: PHAR) announced data from an interim analysis of its open-label...
Tango terminates USP1 inhibitor programme
Clinical Trials Arena via Yahoo Finance· 1 week agoTango Therapeutics has terminated the development of its TNG348 programme after data emerged from the Phase I/II trial showing that the therapy may cause...
Director Adelene Perkins Sells 410,196 Shares of Infinity Pharmaceuticals Inc (INFI)
GuruFocus.com via Yahoo Finance· 9 months agoOn September 12, 2023, Adelene Perkins, a director at Infinity Pharmaceuticals Inc, sold 410,196...
Strength Seen in Pharming Group N.V. Sponsored ADR (PHAR): Can Its 5.2% Jump Turn into More...
Zacks via Yahoo Finance· 1 year agoPharming Group N.V. Sponsored ADR (PHAR) witnessed a jump in share price last session on...
